These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 9056674)
1. AML1a but not AML1b inhibits erythroid differentiation induced by sodium butyrate and enhances the megakaryocytic differentiation of K562 leukemia cells. Niitsu N; Yamamoto-Yamaguchi Y; Miyoshi H; Shimizu K; Ohki M; Umeda M; Honma Y Cell Growth Differ; 1997 Mar; 8(3):319-26. PubMed ID: 9056674 [TBL] [Abstract][Full Text] [Related]
2. Effects of the antisense myb expression on hemin- and erythropoietin-induced erythroid differentiation of K562 cells. Kamano H; Tanaka T; Ohnishi H; Kubota Y; Ikeda K; Takahara J; Irino S; Ottalenghi S Biochem Mol Biol Int; 1994 Aug; 34(1):85-92. PubMed ID: 7849628 [TBL] [Abstract][Full Text] [Related]
3. Effects of chebulinic acid on differentiation of human leukemia K562 cells. Yi ZC; Wang Z; Li HX; Liu MJ; Wu RC; Wang XH Acta Pharmacol Sin; 2004 Feb; 25(2):231-8. PubMed ID: 14769215 [TBL] [Abstract][Full Text] [Related]
4. Expression of megakaryocytic and erythroid properties in human leukemic cells. Tani T; Ylänne J; Virtanen I Exp Hematol; 1996 Feb; 24(2):158-68. PubMed ID: 8641337 [TBL] [Abstract][Full Text] [Related]
5. Differentiation of K562 leukemia cells along erythroid, macrophage, and megakaryocyte lineages. Sutherland JA; Turner AR; Mannoni P; McGann LE; Turc JM J Biol Response Mod; 1986 Jun; 5(3):250-62. PubMed ID: 2425057 [TBL] [Abstract][Full Text] [Related]
6. 12-O-tetradecanoylphorbol-13-acetate and staurosporine induce increased retinoblastoma tumor suppressor gene expression with megakaryocytic differentiation of leukemic cells. Yen A; Varvayanis S; Platko JD Cancer Res; 1993 Jul; 53(13):3085-91. PubMed ID: 8363661 [TBL] [Abstract][Full Text] [Related]
7. An acute myeloid leukemia gene, AML1, regulates transcriptional activation and hemopoietic myeloid cell differentiation antagonistically by two alternative spliced forms. Tanaka T; Tanaka K; Ogawa S; Kurokawa M; Mitani K; Yazaki Y; Shibata Y; Hirai H Leukemia; 1997 Apr; 11 Suppl 3():299-302. PubMed ID: 9209372 [TBL] [Abstract][Full Text] [Related]
8. Induction of erythroid differentiation of K562 human leukemic cells by herbimycin A, an inhibitor of tyrosine kinase activity. Honma Y; Okabe-Kado J; Hozumi M; Uehara Y; Mizuno S Cancer Res; 1989 Jan; 49(2):331-4. PubMed ID: 2910452 [TBL] [Abstract][Full Text] [Related]
9. Increased expression of AML1 during retinoic-acid-induced differentiation of U937 cells. Tanaka K; Tanaka T; Ogawa S; Kurokawa M; Mitani K; Yazaki Y; Hirai H Biochem Biophys Res Commun; 1995 Jun; 211(3):1023-30. PubMed ID: 7598688 [TBL] [Abstract][Full Text] [Related]
10. HIMeg-1, a cell line derived from a CML patient, is capable of monocytic and megakaryocytic differentiation. Cheng T; Erickson-Miller CL; Li C; Cardier J; Wang Y; Dempsey J; Mogle M; Barbera E; Murphy MJ; Dai W Leukemia; 1995 Jul; 9(7):1257-63. PubMed ID: 7543177 [TBL] [Abstract][Full Text] [Related]
11. Altered queuine modification of transfer RNA involved in the differentiation of human K562 erythroleukemia cells in the presence of distinct differentiation inducers. Chen YL; Wu RT Cancer Res; 1994 Apr; 54(8):2192-8. PubMed ID: 7513611 [TBL] [Abstract][Full Text] [Related]
12. Effects of overexpression of the Ets family transcription factor TEL on cell growth and differentiation of K562 cells. Sakurai T; Yamada T; Kihara-Negishi F; Teramoto S; Sato Y; Izawa T; Oikawa T Int J Oncol; 2003 Jun; 22(6):1327-33. PubMed ID: 12739001 [TBL] [Abstract][Full Text] [Related]
13. Leukemogenesis by the chromosomal translocations. Mitani K Leukemia; 1997 Apr; 11 Suppl 3():294-6. PubMed ID: 9209370 [TBL] [Abstract][Full Text] [Related]
14. Single K562 human leukemia cells express and are inducible for both erythroid and megakaryocytic antigens. Rowley PT; Farley BA; LaBella S; Giuliano R; Leary JF Int J Cell Cloning; 1992 Jul; 10(4):232-40. PubMed ID: 1645031 [TBL] [Abstract][Full Text] [Related]
15. The protein tyrosine phosphatase HePTP regulates nuclear translocation of ERK2 and can modulate megakaryocytic differentiation of K562 cells. Pettiford SM; Herbst R Leukemia; 2003 Feb; 17(2):366-78. PubMed ID: 12592337 [TBL] [Abstract][Full Text] [Related]
16. The t(8;21) fusion protein, AML1/ETO, transforms NIH3T3 cells and activates AP-1. Frank RC; Sun X; Berguido FJ; Jakubowiak A; Nimer SD Oncogene; 1999 Mar; 18(9):1701-10. PubMed ID: 10208431 [TBL] [Abstract][Full Text] [Related]
17. c-Jun blocks cell differentiation but not growth inhibition or apoptosis of chronic myelogenous leukemia cells induced by STI571 and by histone deacetylase inhibitors. Huang HM; Liu JC J Cell Physiol; 2009 Mar; 218(3):568-74. PubMed ID: 19006173 [TBL] [Abstract][Full Text] [Related]
18. Disialoganglioside GD3 synthase expression recruits membrane transglutaminase 2 during erythroid differentiation of the human chronic myelogenous leukemia K562 cells. Kang SK; Kim YS; Kong YJ; Song KH; Chang YC; Park YG; Ko JH; Lee YC; Kim CH Proteomics; 2008 Aug; 8(16):3317-28. PubMed ID: 18690648 [TBL] [Abstract][Full Text] [Related]
19. Levels of Smad7 regulate Smad and mitogen activated kinases (MAPKs) signaling and controls erythroid and megakaryocytic differentiation of erythroleukemia cells. Akel S; Bertolette D; Petrow-Sadowski C; Ruscetti FW Platelets; 2007 Dec; 18(8):566-78. PubMed ID: 18041647 [TBL] [Abstract][Full Text] [Related]
20. Induced myeloid differentiation of K562 cells with downregulation of erythroid and megakaryocytic transcription factors: a novel experimental model for hemopoietic lineage restriction. Green AR; Rockman S; DeLuca E; Begley CG Exp Hematol; 1993 Apr; 21(4):525-31. PubMed ID: 8462662 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]